-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2020-Compendium-TechDoc-rev.pdf
January 01, 2020 - Caveats and Limitations
Missing Data
Our analyses suggest that missing AHA data on insurance products … American
Hospital
Association
(AHA)
Hospital
database for
health services
research and
trend analyses
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2018-Compendium-TechDoc-update.pdf
January 01, 2018 - AHA
Annual
Survey
Database
AHA Hospital
database for
health services
research and
trend analyses … Caveats and Limitations
Missing Data
Our analyses suggest that missing AHA data on insurance products
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2021-Compendium-TechDoc-rev.pdf
January 01, 2021 - Caveats and Limitations
Missing Data
Our analyses suggest that missing AHA data on insurance products … American
Hospital
Association
(AHA)
Hospital
database for
health services
research and
trend analyses
-
www.ahrq.gov/sites/default/files/publications/files/universalicu.pdf
September 01, 2013 - Formal cost
effectiveness analyses are being pursued for the REDUCE MRSA Trial.
-
www.ahrq.gov/sites/default/files/2024-01/higginson-report.pdf
January 01, 2024 - Step 7 — Update Model to Determine Predicted Effectiveness of Prevention Strategies
• Sensitivity analyses
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary17/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing-2013
December 15, 2013 - during the fourth quarter of 2012 for relevant English-language studies, systematic reviews, and meta-analyses
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zmvjborz6pkcGVzgcP5nCw
September 30, 2024 - Analyses from prior reviews of that
evidence were considered foundational evidence for the current
recommendation
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
April 30, 2024 - Analyses from prior reviews of that evidence were considered foundational evidence for the current recommendation
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/behavioral-counseling-interventions-evidence-based-approach
March 04, 2021 - Aligning Evidence With Usefulness in Clinical Settings Evidence-based analyses help define the most effective
-
digital.ahrq.gov/sites/default/files/docs/page/ahrq-health-information-technology-portfolio-2012-annual-report.pdf
January 01, 2012 - ; 2)
secondary data analysis of health IT research;
and 3) economic prospective or retrospective
analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_surveillance.pdf
October 01, 2012 - for qualitative and quantitative signals
The authors of the original CER did not conduct meta-analyses
-
hcup-us.ahrq.gov/reports/methods/2003_04.pdf
January 01, 2003 - Appendix B shows for each Prevention Quality Indicator included in
the NHQR, the analyses performed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_surveillance.pdf
August 30, 2014 - BACKGROUND: Conventional meta-analyses have shown inconsistent results for efficacy of pharmacological
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/point-of-care_research.pdf
April 01, 2014 - review the relevant scientific
literature on topics assigned to them by AHRQ and conduct additional analyses
-
hcup-us.ahrq.gov/datainnovations/clinicalcontentenhancementtoolkit/hi25.jsp
September 01, 2014 - Cost-to-Charge Ratio (CCR) Files
Hospital Market Structure (HMS) Files
Supplemental Variables for Revisit Analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hro-rapid-research.pdf
May 01, 2025 - Intervention period was
divided into 3 years for
analyses.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/asian-nhpi/asian-nhpi-chartbook.pdf
May 15, 2020 - because data were only available for 2013-2015; 4 years of data are
required for inclusion in trend analyses
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/RrE4_peSk5zVH3cCf77at3
June 24, 2025 - Meta-
analyses of screening or treatment studies was not conducted be-
cause there were too few trials
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGsDefManualV25Public.pdf
June 01, 2009 - These
grouping are then subjected to statistical analyses to determine the final APS-DRGs®
classifications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
September 01, 2011 - literature for differing efficacy of
atypicals by clinical subsets did not reveal studies
reporting subgroup analyses